CCMI
BIO icon

Creative Capital Management Investments’s Bio-Rad Laboratories Class A BIO Stock Holding History

Creative Capital Management Investments’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.06K Buy
+7
New +$1.99K ﹤0.01% 789

Other funds holding BIO

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
SGH
Sivik Global Healthcare Greenwich, Connecticut $132M AUM 24.1% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
FISPB
Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Creative Capital Management Investments's BIO Position: Q2 2026 in Review

Creative Capital Management Investments opened a new position in Bio-Rad Laboratories Class A (BIO) in Q2 2026: 7 shares worth $2.06K. The stake represents ﹤0.01% of the portfolio and ranks #789 among its holdings.

72 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Creative Capital Management Investments held 7 shares of Bio-Rad Laboratories Class A worth $2.06K as of Q2 2026.
  • Bio-Rad Laboratories Class A was a new Creative Capital Management Investments position in Q2 2026.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Creative Capital Management Investments's portfolio in Q2 2026, its #789 holding.
  • 72 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.